Neautus
Neautus provides traditional Chinese medicine decoction-ready products and consumer wellness products, including exports through localized operations in selected international markets.
Neautus (Ticker: 2206 HK) provides traditional Chinese medicine products prepared for decoction. Its range includes more than 770 types and 4,900 varieties. The company uses digital technologies in production and quality control.
Neautus expects to begin trading on the Hong Kong Stock Exchange on November 11, 2026. The global offering comprises H shares. Its proposed base offering comprises 6,517,300 shares at an indicative HKD 40.20–50.55 per share. At the indicative midpoint, the offering would represent approximately HKD 295.72 million in gross proceeds, or approximately $37.69 million. Neautus also offers consumer wellness products and exports traditional Chinese medicine wellness products through localized operations in selected international markets. It operates across most provinces in mainland China, as well as Hong Kong, Taiwan, Vietnam and Malaysia.
Prepared with IPOX® AI assistance. Information may contain errors.
Prepared with IPOX® AI assistance. Information may contain errors.